JP2020518608A5 - - Google Patents

Download PDF

Info

Publication number
JP2020518608A5
JP2020518608A5 JP2019560139A JP2019560139A JP2020518608A5 JP 2020518608 A5 JP2020518608 A5 JP 2020518608A5 JP 2019560139 A JP2019560139 A JP 2019560139A JP 2019560139 A JP2019560139 A JP 2019560139A JP 2020518608 A5 JP2020518608 A5 JP 2020518608A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
busulfan
cyclodextrin
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019560139A
Other languages
English (en)
Japanese (ja)
Other versions
JP7204670B2 (ja
JP2020518608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/030728 external-priority patent/WO2018204535A1/en
Publication of JP2020518608A publication Critical patent/JP2020518608A/ja
Publication of JP2020518608A5 publication Critical patent/JP2020518608A5/ja
Priority to JP2022212559A priority Critical patent/JP7597778B2/ja
Application granted granted Critical
Publication of JP7204670B2 publication Critical patent/JP7204670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560139A 2017-05-03 2018-05-02 シクロデキストリン及びブスルファンを含有する組成物 Active JP7204670B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022212559A JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762500970P 2017-05-03 2017-05-03
US62/500,970 2017-05-03
PCT/US2018/030728 WO2018204535A1 (en) 2017-05-03 2018-05-02 Composition containing cyclodextrin and busulfan

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022212559A Division JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Publications (3)

Publication Number Publication Date
JP2020518608A JP2020518608A (ja) 2020-06-25
JP2020518608A5 true JP2020518608A5 (cg-RX-API-DMAC10.html) 2021-06-17
JP7204670B2 JP7204670B2 (ja) 2023-01-16

Family

ID=64014433

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560139A Active JP7204670B2 (ja) 2017-05-03 2018-05-02 シクロデキストリン及びブスルファンを含有する組成物
JP2022212559A Active JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022212559A Active JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Country Status (10)

Country Link
US (2) US20180318249A1 (cg-RX-API-DMAC10.html)
EP (1) EP3618825A4 (cg-RX-API-DMAC10.html)
JP (2) JP7204670B2 (cg-RX-API-DMAC10.html)
KR (1) KR20190141244A (cg-RX-API-DMAC10.html)
CN (1) CN110831588B (cg-RX-API-DMAC10.html)
AU (1) AU2018263924B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019023074A2 (cg-RX-API-DMAC10.html)
CA (1) CA3062308A1 (cg-RX-API-DMAC10.html)
MX (2) MX2019013053A (cg-RX-API-DMAC10.html)
WO (1) WO2018204535A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109078005B (zh) * 2018-08-07 2021-11-26 江苏领航生物科技有限公司 一种白消安组合物及其制备方法和应用
KR20220083773A (ko) * 2019-10-18 2022-06-20 이뮤노믹 쎄라퓨틱스, 인크. 암 항원을 포함하는 개선된 lamp 구축물
CN113679852B (zh) * 2021-09-13 2022-11-15 天津师范大学 一种水溶性主客体复合物及其制备与应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426011A (en) 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR927003645A (ko) 1990-05-21 1992-12-18 후지다 히로미찌 씨클로덱스트린 유도체
US5180716A (en) 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5430057A (en) 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US5874418A (en) 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
ES2257795T3 (es) 1997-07-01 2006-08-01 Pfizer Products Inc. Procedimiento para producir una ciclodextrina.
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
WO2004022100A1 (en) 2002-08-15 2004-03-18 Yunqing Liu Soild nano pharmaceutical formulation and preparation method thereof
MXPA05002728A (es) 2002-09-13 2005-07-25 Cydex Inc Capsulas que contienen composiciones de relleno acuoso estabilizadas con ciclodextrina derivada.
WO2005042584A2 (en) 2003-10-31 2005-05-12 The University Of Kansas Sulfoalkyl ether-alkyl ether cyclodextrin derivatives
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
SI2952197T1 (sl) 2005-10-26 2017-09-29 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega
WO2007062403A2 (en) * 2005-11-28 2007-05-31 Vernon D Rowe Compositions useful for reducing nephrotoxicity and methods of use thereof
US7658913B2 (en) * 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
NZ575394A (en) * 2006-10-20 2012-01-12 Icos Corp Compositions of chk1 inhibitors and cyclodextrin
KR101522918B1 (ko) * 2009-05-29 2015-05-27 사이덱스 파마슈티칼스, 인크. 사이클로덱스트린 유도체를 포함하는 주사용 멜팔란 조성물 및 이의 제조 및 사용 방법
AU2013259573B2 (en) * 2012-05-08 2018-02-15 Onyx Therapeutics, Inc. Cyclodextrin complexation Methods for Formulating Peptide Proteasome Inhibitors
CN105726467A (zh) * 2014-12-09 2016-07-06 四川科瑞德制药有限公司 一种白消安注射液及其制备方法

Similar Documents

Publication Publication Date Title
JP6173502B2 (ja) 注射用徐放性製剤
JP5089004B2 (ja) ボリコナゾールを含有する薬剤製剤
JP6218204B2 (ja) カテコール基を有するセファロスポリン類を含有する製剤
KR0136722B1 (ko) 택산류 유도체를 기재로한 신규한 조성물
KR100330316B1 (ko) 탁산유도체를기재로한주사용조성물
JP2005523305A (ja) フマギロール誘導体又はその塩の包接化合物、及び該包接化合物を含む医薬組成物
PT758231E (pt) Composicoes farmaceuticas a base de derivados da classe dos taxanos
JP2010528045A5 (cg-RX-API-DMAC10.html)
CN113271923A (zh) 呋塞米的药物组合物及其用途
JP7597778B2 (ja) シクロデキストリン及びブスルファンを含有する組成物
RU2008146217A (ru) Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование
JP6450356B2 (ja) 液状医薬製剤
CN116211831A (zh) 脂质基质局部注射制剂
RU2004133387A (ru) Фармацевтический препарат с немедленным высвобождением
ES2959891T3 (es) Producción de trans-[tetraclorobis(1H-indazol)rutenato (III)] y composiciones del mismo
RU2013107761A (ru) Фармацевтическая композиция, содержащая триптофановое производное
BR112013005763B1 (pt) Injeção de 5a-androstano-3ss, 5, 6ss-triol e método para prrparação da injeção
RU2428427C2 (ru) Стероидные соединения в качестве ингибиторов стероидсульфатазы
RU2443432C2 (ru) Фармацевтическая композиция для введения инъекцией
KR20200059221A (ko) 시포니모드를 포함하는 비경구 제형
BR112015015202B1 (pt) Composição
CN1290506C (zh) 药物组合物
KR100466955B1 (ko) 항종양제함유조성물
JP2019532927A5 (cg-RX-API-DMAC10.html)
JP3990728B2 (ja) N−[4−オキソ−2−(1h−テトラゾール−5−イル)−4h−1−ベンゾピラン−8−イル]−4−(4−フェニルブトキシ)ベンズアミドの塩